Bioorthogonal epigenetic anchoring of heterochromatin to the nuclear lamina reverses senescence and osteoarthritis.

Xunshan Ren, Huangming Zhuang, Junming Zhu, Hongbao Jiang, Jinxuan Zhang, Yuelong Zhang, Rongling Feng, Rui Shi, Ruijun Zhang, Le Li, Miradj Siddick Adam, Panghu Zhou

Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China; Central Laboratory of Renmin Hospital of Wuhan University, Wuhan, China.Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China; Central Laboratory of Renmin Hospital of Wuhan University, Wuhan, China. · pubmed

Paper

Abstract

An increase in the number of senescent cells with advancing age is a major predisposing factor for aging-related osteoarthritis (OA). However, effective intervention strategies targeting cellular senescence have yet to be developed. Increasing evidence suggests that rising epigenetic entropy, specifically the detachment of heterochromatin from the nuclear envelope, is a driver of cellular senescence.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Bioorthogonal epigenetic anchoring of heterochromatin to the nuclear lamina reverses senescence and osteoarthritis. This study presents an incremental mechanistic advance in understanding epigenetic entropy as a driver of senescence, but the specific therapeutic application to osteoarthritis limits its broad impact on fundamental longevity research compared to interventions targeting core aging hallmarks directly.

Author of this paper? Send a correction.